India May Suffer Huge Loss on Pharma Exports

Monday, July 27, 2015

Source: The Economic Times

India is set to suffer at least $1 billion (Rs 6,300 crore) of loss in export of pharmaceutical products this fiscal following the ban on around 700 generic drugs by the European Commission for alleged manipulation of clinical trials by the Hyderabad headquartered contract research and clinical trials firm GVK Bio.

View All News »